Products

DungeonTome

AI-native

Transform your D&D sessions into insanely useful summaries. Record your campaigns and let DungeonTome do the note-taking for you.

dungeontome.app App Store Google PlayGames / Game Discovery, Guides & Tools

AI Benchmark
Desktop
Mobile
Monthly visits
<5K
Oct 2026
Public revenue
Undisclosed
No public revenue evidence yet
Entry price
Unknown
Subscription model, plan pricing not identified yet
Creators
Jamie Goodson
No social account linked
Launched
17mo ago
2025-07-03 · Est.

Traffic

Monthly visitsData through Oct 2026

Marketing moves

Launches, search & content, referrals, promotions
  • Launched on Uneed (#9)Launch

    DungeonTome — Epic AI summaries of your D&D sessions

    Jul 6, 2025 · 17mo agoLaunch page

  • Launched on Product HuntLaunch

    Epic AI summaries of your D&D sessions

    Jul 3, 2025 · 17mo agoLaunch page

Traffic sources

Oct 2026

Traffic breakdown

Channels

No data yet

Countries

No data yet

Search

Domain authority —Domain registered Unknown

KeywordMonthly volume
dungeontome30

Traffic data: Vaneform

Pricing

Pricing page not identified yet, or no public pricing listed.

Pages & changes

Tracked since 2025-07-03

Key pages

Weekly snapshots
Home
dungeontome.app/ Snapshot 2026-11-09

Changes

No pricing, plan, or positioning changes detected since tracking started.

Questions & evidence

How much website traffic does DungeonTome get?
Vaneform estimates <5K website visits in 2026-10. Visits can include repeat visits; this estimate measures web traffic separately from paying customers or revenue.Source
What is DungeonTome and what platforms does it support?
DungeonTome is catalogued under Game Discovery, Guides & Tools: Transform your D&D sessions into insanely useful summaries. Record your campaigns and let DungeonTome do the note-taking for you. Supported platforms: Mobile App.

Related products in this category

Games / Game Discovery, Guides & Tools

These products share a catalog category. Compare customer tasks, features and deployment requirements before treating them as alternatives.